Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50592032 (CHEMBL5194370 | US20240018135, Code C-8) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458383 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.214 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458383 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.214 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458383 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.214 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458387 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.385 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458387 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.385 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458387 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.385 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50323697 ((3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(HYDROXYMETHYL...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE MMDB PC cid PC sid PDB UniChem Similars | PDB Article PubMed | n/a | n/a | 0.410 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human O-GlcNAcase | J Med Chem 62: 10059-10061 (2019) Article DOI: 10.1021/acs.jmedchem.9b01668 BindingDB Entry DOI: 10.7270/Q2PV6PM2 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458382 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.465 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458382 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.465 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458382 (1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.465 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458386 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.495 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458386 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.495 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458386 (1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.495 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458385 (1-[3-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.592 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458385 (1-[3-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.592 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458385 (1-[3-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.592 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458384 (1-[6-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.782 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10836773 (2020) BindingDB Entry DOI: 10.7270/Q2PG1VVK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458384 (1-[6-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.782 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ... | Citation and Details Article DOI: 10.1021/acsmedchemlett.1c00259 BindingDB Entry DOI: 10.7270/Q2NG4VBP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM458384 (1-[6-[(3R,5S)-1-[(6-fluoro-2-methyl-1,3-benzothiaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.782 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company US Patent | Assay Description The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-... | US Patent US10752632 (2020) BindingDB Entry DOI: 10.7270/Q2T72MHD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM532950 ((?)-5-fluoro-6-[1-[4-(5-methyl-1,3,4-oxadiazol-2-y...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.13 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The assay buffer is prepared to give a final concentration of 50 mM H2NaPO3—HNa2PO3, 0.01% bovine serum albumin and 0.01% Triton™ X-100 in water, at ... | Citation and Details BindingDB Entry DOI: 10.7270/Q29S1V76 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM532948 ((?)-6-[1-[4-(5-methyl-1,3,4-oxadiazol-2-yl)-1-pipe...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.24 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The assay buffer is prepared to give a final concentration of 50 mM H2NaPO3—HNa2PO3, 0.01% bovine serum albumin and 0.01% Triton™ X-100 in water, at ... | Citation and Details BindingDB Entry DOI: 10.7270/Q29S1V76 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50323697 ((3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(HYDROXYMETHYL...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE MMDB PC cid PC sid PDB UniChem Similars | PDB Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Citation and Details Article DOI: 10.1016/j.ejmech.2022.114444 BindingDB Entry DOI: 10.7270/Q2MC9402 | ||||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508751 (CHEMBL4559427) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508743 (CHEMBL4460141) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613669 (US11731972, Compound 11) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613711 (US11731972, Compound 59) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613712 (US11731972, Compound 60) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613670 (US11731972, Compound 12) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613730 (US11731972, Compound IA5) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613731 (US11731972, Compound IA6) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM613729 (US11731972, Compound IA4) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2BP06X6 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508749 (CHEMBL4546591) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM645669 (US20240018135, Code A-34S) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM205424 (US9243020, 19 | US9815861, Example 19) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human O-GlcNAcase | J Med Chem 62: 10059-10061 (2019) Article DOI: 10.1021/acs.jmedchem.9b01668 BindingDB Entry DOI: 10.7270/Q2PV6PM2 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508747 (CHEMBL4591634) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508753 (CHEMBL4580690) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508752 (CHEMBL4474295) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50549046 (CHEMBL4741417) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of OGA in HEK293 cells induced with human Tau P30IL mutant assessed as increase in O-GlcNAcylated protein levels measured after 6 hrs by H... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01479 BindingDB Entry DOI: 10.7270/Q23F4T82 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50549046 (CHEMBL4741417) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of OGA in HEK293 cells induced with human Tau P30IL mutant assessed as increase in O-GlcNAcylated protein levels measured after 6 hrs by H... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01479 BindingDB Entry DOI: 10.7270/Q23F4T82 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50557163 (CHEMBL4781640) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human OGA expressed in Expi293 (HEK293) cells using 4-methylumbelliferyl-N-acetyl-beta-D-glucosaminide dihydrate as fluorog... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01712 BindingDB Entry DOI: 10.7270/Q2NS0ZKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508750 (CHEMBL4521475) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508748 (CHEMBL4440890) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50557156 (CHEMBL4757008) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid PDB UniChem | Article PubMed | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human OGA expressed in Expi293 (HEK293) cells using 4-methylumbelliferyl-N-acetyl-beta-D-glucosaminide dihydrate as fluorog... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01712 BindingDB Entry DOI: 10.7270/Q2NS0ZKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM645643 (N-([1,1'-biphenyl]-4-ylmethyl)- 2-(4-((2-acetamido...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50557162 (CHEMBL4763159) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human OGA expressed in Expi293 (HEK293) cells using 4-methylumbelliferyl-N-acetyl-beta-D-glucosaminide dihydrate as fluorog... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01712 BindingDB Entry DOI: 10.7270/Q2NS0ZKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50508742 (CHEMBL4558360) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Drexel University Curated by ChEMBL | Assay Description Inhibition of recombinant human full length OGA using FM-GlcNAc as substrate preincubated for 60 mins followed by substrate addition and measured aft... | ACS Med Chem Lett 10: (2019) Article DOI: 10.1021/acsmedchemlett.8b00653 BindingDB Entry DOI: 10.7270/Q21839T9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50549046 (CHEMBL4741417) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of OGA in HEK293 cells induced with human Tau P30IL mutant assessed as increase in O-GlcNAcylated protein levels measured after 6 hrs by H... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01479 BindingDB Entry DOI: 10.7270/Q23F4T82 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50592008 (CHEMBL5171168 | US20240018135, Code A-34) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Citation and Details Article DOI: 10.1016/j.ejmech.2022.114444 BindingDB Entry DOI: 10.7270/Q2MC9402 | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein O-GlcNAcase (Homo sapiens (Human)) | BDBM50557155 (CHEMBL4789831) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of full-length human OGA expressed in Expi293 (HEK293) cells using 4-methylumbelliferyl-N-acetyl-beta-D-glucosaminide dihydrate as fluorog... | Citation and Details Article DOI: 10.1021/acs.jmedchem.0c01712 BindingDB Entry DOI: 10.7270/Q2NS0ZKN | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1402 total ) | Next | Last >> |